Just got tapped in ABBV, Funny Don't know what this company does
Note:
Don't know what this symbol or company does nor do I care, As technical analyst that's not my job,
I have been keeping an eye on this & have been waiting as usual only few things is going to happen:
1. SL hit.
2. BE hit.
3. Hopefully Profit booking.
4. But also on Monday either a gap up
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1
No trades
No trades
Compare with AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1
2,750 ARS
5.21 T ARS
76.17 T ARS
Details
Sector
Industry
CEO
Robert A. Michael
Website
Headquarters
North Chicago
Founded
2011
IPO date
Jan 2, 2013
ISIN
ARBCOM4603M9
FIGI
BBG00ZL7CCS3
Identifiers
ISIN ARBCOM4603M9
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
AbbVie (ABBV) Breaking Above a Major Resistance Zone
AbbVie has decisively broken above the long-standing resistance around $245, turning a key supply zone into potential support. The strong bullish breakout suggests renewed buying momentum, although a short-term pullback to retest the breakout level remains possible before the next leg higher.
Sho
$ABBV — WEDGE BREAK ON A VOLUME EXPLOSION 📊 NYSE:ABBV — WEDGE BREAK ON A VOLUME EXPLOSION | 1W
Weekly close $253.35, +𝟭𝟳% on the week. This is a structural break, not a drift.
💥 THE VOLUME TELL
𝟴𝟳.𝟱𝗠 shares — the largest volume bar on the entire chart, by a wide margin. A breakout this size on volume this heavy is the confirmation you w
AbbVie at a Breakout Decision PointAbbVie is trading near the upper boundary of a descending channel, making this a critical area where the stock must either break out or remain trapped in the corrective structure.
Short-Term Outlook
A daily close above $230 would strengthen the bullish breakout scenario.
Targets: $235 → $245 → $
abbv retest and breakout on supportabbv has a nice break and retest of old resistance which I'm calling support now.
we also have an inverted head and shoulders on the daily
I'm looking for a strong close on the weekly tomorrow for more conformation.
but looking at the weekly today I see strong buying
on the flip side there is
abbv if you follow me, we have been waiting for this moment, and we now have a strong confluence of support.
on smaller time we now have trend and conformation on the daily so all I'm looking for is conformation on a weekly close.
also, we still are in bullish channel
I don't see us going lower, but I
ABBV short idea ABBV looks to have formed a triple top / channel resistance and has since broken down into a tightening symmetrical triangle. Price is currently holding the 50% fib support at ~$204, with the .618 below at ~$195.
We’ve seen multiple tests of the $204 support, and each bounce is getting weaker while
NYSE – S&P 500 | AbbVie Inc. | 23 Mar 2026Part of the ongoing S&P 500 Structural Census study.
AbbVie reflects a sustained impulsive structure following the post-2020 expansion phase, with price maintaining higher highs and higher lows.
The current phase represents consolidation within the broader uptrend, with no confirmed structural wea
AbbVie Under PressureTechnical Analysis
The daily chart shows a descending channel, indicating a correction after a strong rally.
Key points:
• Strong prior uptrend
• Current corrective channel
• Price near channel support
• Moving average acting as resistance
Short-Term Scenarios
Bullish Bounce
If price hol
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
6.054% YTM
Maturity dateMar 15, 2064
Coupon5.50% (Fixed)
6.052% YTM
Maturity dateMar 15, 2066
Coupon5.65% (Fixed)
5.991% YTM
Maturity dateNov 21, 2049
Coupon4.25% (Fixed)
5.988% YTM
Maturity dateMay 14, 2046
Coupon4.45% (Fixed)
5.987% YTM
Maturity dateMar 15, 2056
Coupon5.55% (Fixed)
5.982% YTM
Maturity dateMar 15, 2054
Coupon5.40% (Fixed)
5.973% YTM
Maturity dateMar 15, 2055
Coupon5.60% (Fixed)
5.969% YTM
Maturity dateNov 14, 2048
Coupon4.88% (Fixed)
5.950% YTM
Maturity dateMay 14, 2045
Coupon4.70% (Fixed)
5.922% YTM
Maturity dateMar 15, 2045
Coupon4.75% (Fixed)
5.891% YTM
Maturity dateJun 15, 2044
Coupon4.85% (Fixed)
See all ABBV bonds









